4.8 (184) · $ 12.99 · In stock
Sanofi announces encouraging results for its booster against Omicron variant – Euractiv
Sanofi, GSK score late win with EU COVID booster approval
GSK's RSV vaccine Arexvy is effective in adults aged 50-59
EC grants approval for Sanofi-GSK's Covid-19 booster
Sanofi, GSK to seek regulatory approval for COVID vaccine
EU to receive 300 million COVID-19 vaccine doses from Sanofi and GSK
Recon: Sanofi, GSK to seek approval for COVID vaccine candidate; Novavax begins shipping vaccines to EU states
Sanofi/GSK COVID-19 Vaccine: What You Should Know
Sanofi, GSK to seek authorization for COVID-19 vaccine
Looking beyond COVID-19 vaccine phase 3 trials
EMA starts review of Sanofi-GSK COVID vaccine application
Global PPE (@Global_PPE_Inc) / X